TY - JOUR
T1 - Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program
T2 - A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW) Project participants, Hawai‘i, 2012
AU - Salek, Thomas P.
AU - Katz, Alan R.
AU - Lenze, Stacy M.
AU - Lusk, Heather M.
AU - Li, Dongmei
AU - Des Jarlais, Don C.
N1 - Publisher Copyright:
© 2017 Elsevier B.V.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2017/10
Y1 - 2017/10
N2 - Background The Community Health Outreach Work to Prevent AIDS (CHOW) Project is the first and longest-standing statewide integrated and funded needle and syringe exchange program (SEP) in the US. Initiated on O‘ahu in 1990, CHOW expanded statewide in 1993. The purpose of this study is to estimate the prevalences of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infection, and to characterize risk behaviors associated with infection among clients of a long-standing SEP through the analysis of the 2012 CHOW evaluation data. Methods A cross-sectional sample of 130 CHOW Project clients was selected from January 1, 2012 through December 31, 2012. Questionnaires captured self-reported exposure information. HIV and HCV antibodies were detected via rapid, point-of-care FDA-approved tests. Log-binomial regressions were used to estimate prevalence proportion ratios (PPRs). A piecewise linear log-binomial regression model containing 1 spline knot was used to fit the age–HCV relationship. Results The estimated seroprevalence of HCV was 67.7% (95% confidence interval [CI] = 59.5–75.8%). HIV seroprevalence was 2.3% (95% CI = 0–4.9%). Anti-HCV prevalence demonstrated age-specific patterns, ranging from 31.6% through 90.9% in people who inject drugs (PWID) <30 to ≥60 years respectively. Age (continuous/year) prior to spline knot at 51.5 years (adjusted PPR [APPR] = 1.03; 95% CI = 1.02–1.05) and months exchanging syringes (quartiles) (APPR = 1.92; 95% CI = 1.3–3.29) were independently associated with anti-HCV prevalence. Conclusion In Hawai‘i, HCV prevalence among PWID is hyperendemic demonstrating age- and SEP duration-specific trends. Relatively low HIV prevalence compared with HCV prevalence reflects differences in transmissibility of these 2 blood-borne pathogens and suggests much greater efficacy of SEP for HIV prevention.
AB - Background The Community Health Outreach Work to Prevent AIDS (CHOW) Project is the first and longest-standing statewide integrated and funded needle and syringe exchange program (SEP) in the US. Initiated on O‘ahu in 1990, CHOW expanded statewide in 1993. The purpose of this study is to estimate the prevalences of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infection, and to characterize risk behaviors associated with infection among clients of a long-standing SEP through the analysis of the 2012 CHOW evaluation data. Methods A cross-sectional sample of 130 CHOW Project clients was selected from January 1, 2012 through December 31, 2012. Questionnaires captured self-reported exposure information. HIV and HCV antibodies were detected via rapid, point-of-care FDA-approved tests. Log-binomial regressions were used to estimate prevalence proportion ratios (PPRs). A piecewise linear log-binomial regression model containing 1 spline knot was used to fit the age–HCV relationship. Results The estimated seroprevalence of HCV was 67.7% (95% confidence interval [CI] = 59.5–75.8%). HIV seroprevalence was 2.3% (95% CI = 0–4.9%). Anti-HCV prevalence demonstrated age-specific patterns, ranging from 31.6% through 90.9% in people who inject drugs (PWID) <30 to ≥60 years respectively. Age (continuous/year) prior to spline knot at 51.5 years (adjusted PPR [APPR] = 1.03; 95% CI = 1.02–1.05) and months exchanging syringes (quartiles) (APPR = 1.92; 95% CI = 1.3–3.29) were independently associated with anti-HCV prevalence. Conclusion In Hawai‘i, HCV prevalence among PWID is hyperendemic demonstrating age- and SEP duration-specific trends. Relatively low HIV prevalence compared with HCV prevalence reflects differences in transmissibility of these 2 blood-borne pathogens and suggests much greater efficacy of SEP for HIV prevention.
KW - Cross-sectional studies
KW - HIV
KW - Hepatitis C
KW - Needle-exchange programs
UR - http://www.scopus.com/inward/record.url?scp=85026667129&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85026667129&partnerID=8YFLogxK
U2 - 10.1016/j.drugpo.2017.06.009
DO - 10.1016/j.drugpo.2017.06.009
M3 - Article
C2 - 28779632
AN - SCOPUS:85026667129
VL - 48
SP - 34
EP - 43
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
SN - 0955-3959
ER -